309 related articles for article (PubMed ID: 10368279)
1. The active conformation of plasminogen activator inhibitor 1, a target for drugs to control fibrinolysis and cell adhesion.
Sharp AM; Stein PE; Pannu NS; Carrell RW; Berkenpas MB; Ginsburg D; Lawrence DA; Read RJ
Structure; 1999 Feb; 7(2):111-8. PubMed ID: 10368279
[TBL] [Abstract][Full Text] [Related]
2. Plasminogen activator inhibitor 1. Structure of the native serpin, comparison to its other conformers and implications for serpin inactivation.
Nar H; Bauer M; Stassen JM; Lang D; Gils A; Declerck PJ
J Mol Biol; 2000 Mar; 297(3):683-95. PubMed ID: 10731421
[TBL] [Abstract][Full Text] [Related]
3. The conversion of active to latent plasminogen activator inhibitor-1 is an energetically silent event.
Boudier C; Gils A; Declerck PJ; Bieth JG
Biophys J; 2005 Apr; 88(4):2848-54. PubMed ID: 15653733
[TBL] [Abstract][Full Text] [Related]
4. Different structural requirements for plasminogen activator inhibitor 1 (PAI-1) during latency transition and proteinase inhibition as evidenced by phage-displayed hypermutated PAI-1 libraries.
Stoop AA; Eldering E; Dafforn TR; Read RJ; Pannekoek H
J Mol Biol; 2001 Jan; 305(4):773-83. PubMed ID: 11162091
[TBL] [Abstract][Full Text] [Related]
5. Interfering with the inhibitory mechanism of serpins: crystal structure of a complex formed between cleaved plasminogen activator inhibitor type 1 and a reactive-centre loop peptide.
Xue Y; Björquist P; Inghardt T; Linschoten M; Musil D; Sjölin L; Deinum J
Structure; 1998 May; 6(5):627-36. PubMed ID: 9634700
[TBL] [Abstract][Full Text] [Related]
6. RNA aptamers as conformational probes and regulatory agents for plasminogen activator inhibitor-1.
Madsen JB; Dupont DM; Andersen TB; Nielsen AF; Sang L; Brix DM; Jensen JK; Broos T; Hendrickx ML; Christensen A; Kjems J; Andreasen PA
Biochemistry; 2010 May; 49(19):4103-15. PubMed ID: 20387790
[TBL] [Abstract][Full Text] [Related]
7. Distinct encounter complexes of PAI-1 with plasminogen activators and vitronectin revealed by changes in the conformation and dynamics of the reactive center loop.
Qureshi T; Goswami S; McClintock CS; Ramsey MT; Peterson CB
Protein Sci; 2016 Feb; 25(2):499-510. PubMed ID: 26548921
[TBL] [Abstract][Full Text] [Related]
8. High quality structure of cleaved PAI-1-stab.
Dewilde M; Strelkov SV; Rabijns A; Declerck PJ
J Struct Biol; 2009 Feb; 165(2):126-32. PubMed ID: 19059484
[TBL] [Abstract][Full Text] [Related]
9. Specific interactions of serpins in their native forms attenuate their conformational transitions.
Na YR; Im H
Protein Sci; 2007 Aug; 16(8):1659-66. PubMed ID: 17600149
[TBL] [Abstract][Full Text] [Related]
10. Type-1 plasminogen-activator inhibitor -- conformational differences between latent, active, reactive-centre-cleaved and plasminogen-activator-complexed forms, as probed by proteolytic susceptibility.
Egelund R; Schousboe SL; Sottrup-Jensen L; Rodenburg KW; Andreasen PA
Eur J Biochem; 1997 Sep; 248(3):775-85. PubMed ID: 9342229
[TBL] [Abstract][Full Text] [Related]
11. Resolution of Michaelis complex, acylation, and conformational change steps in the reactions of the serpin, plasminogen activator inhibitor-1, with tissue plasminogen activator and trypsin.
Olson ST; Swanson R; Day D; Verhamme I; Kvassman J; Shore JD
Biochemistry; 2001 Oct; 40(39):11742-56. PubMed ID: 11570875
[TBL] [Abstract][Full Text] [Related]
12. VLHL plasminogen activator inhibitor spontaneously reactivates from the latent to active form.
Jankun J; Aleem AM; Selman SH; Basrur V; Skrzypczak-Jankun E
Int J Mol Med; 2009 Jan; 23(1):57-63. PubMed ID: 19082507
[TBL] [Abstract][Full Text] [Related]
13. Rational design of complex formation between plasminogen activator inhibitor-1 and its target proteinases.
Aertgeerts K; De Ranter CJ; Booth NA; Declerck PJ
J Struct Biol; 1997 Apr; 118(3):236-42. PubMed ID: 9169233
[TBL] [Abstract][Full Text] [Related]
14. Identification of a target site in plasminogen activator inhibitor-1 that allows neutralization of its inhibitor properties concomitant with an allosteric up-regulation of its antiadhesive properties.
Ngo TH; Hoylaerts MF; Knockaert I; Brouwers E; Declerck PJ
J Biol Chem; 2001 Jul; 276(28):26243-8. PubMed ID: 11342530
[TBL] [Abstract][Full Text] [Related]
15. Protein conformational change delayed by steric hindrance from an N-linked glycan.
Bager R; Johansen JS; Jensen JK; Stensballe A; Jendroszek A; Buxbom L; Sørensen HP; Andreasen PA
J Mol Biol; 2013 Aug; 425(16):2867-77. PubMed ID: 23702291
[TBL] [Abstract][Full Text] [Related]
16. The reactive-center loop of active PAI-1 is folded close to the protein core and can be partially inserted.
Hägglöf P; Bergström F; Wilczynska M; Johansson LB; Ny T
J Mol Biol; 2004 Jan; 335(3):823-32. PubMed ID: 14687577
[TBL] [Abstract][Full Text] [Related]
17. Plasminogen activator inhibitor-1 is locked in active conformation and polymerizes upon binding ligands neutralizing its activity.
Jankun J; Specht Z; Szkudlarek M; Greenfield R; Gaikwad B; Trifonov L; Vaugeois J; Aleem AM; Basrur V; Selman SH; Zavodszky MI; Skrzypczak-Jankun E
Int J Mol Med; 2006 Mar; 17(3):437-47. PubMed ID: 16465390
[TBL] [Abstract][Full Text] [Related]
18. How vitronectin binds PAI-1 to modulate fibrinolysis and cell migration.
Zhou A; Huntington JA; Pannu NS; Carrell RW; Read RJ
Nat Struct Biol; 2003 Jul; 10(7):541-4. PubMed ID: 12808446
[TBL] [Abstract][Full Text] [Related]
19. Crystal structure of plasminogen activator inhibitor-1 in an active conformation with normal thermodynamic stability.
Jensen JK; Thompson LC; Bucci JC; Nissen P; Gettins PG; Peterson CB; Andreasen PA; Morth JP
J Biol Chem; 2011 Aug; 286(34):29709-17. PubMed ID: 21697084
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of the proteinase specificity in wild-type and stabilized plasminogen activator inhibitor-1: evidence for contribution of intramolecular flexibility.
De Taeye B; Gils A; Vleugels N; Rabijns A; Declerck PJ
Biochem Biophys Res Commun; 2004 Aug; 321(3):746-51. PubMed ID: 15358169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
